Clinical Trial Update: Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the combination of stereotactic body radiotherapy (SBRT) and transarterial chemoembolization (TACE) for unresectable hepatocellular…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Stanford University | Conditions: Carcinoma, Hepatocellular, Hepatobiliary Neoplasm | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2015-05-22